Home » Stocks » DVA

DaVita Inc. (DVA)

Stock Price: $122.53 USD -1.81 (-1.46%)
Updated May 18, 2021 12:06 PM EDT - Market open
Market Cap 13.20B
Revenue (ttm) 11.53B
Net Income (ttm) 771.45M
Shares Out 109.01M
EPS (ttm) 6.47
PE Ratio 18.94
Forward PE 15.34
Dividend n/a
Dividend Yield n/a
Trading Day May 18
Last Price $122.53
Previous Close $124.34
Change ($) -1.81
Change (%) -1.46%
Day's Open 124.39
Day's Range 121.50 - 124.64
Day's Volume 212,487
52-Week Range 75.30 - 129.59

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

DENVER, May 13, 2021 /PRNewswire/ --  DaVita Kidney Care today announced that 60 of its nephrology nurses were honored with The DAISY Award for Extraordinary Nurses® during National Nurses Week. The awa...

5 days ago - PRNewsWire

Investor confidence is high on the DaVita (DVA) stock, courtesy of its solid prospects.

6 days ago - Zacks Investment Research

DENVER, May 10, 2021 /PRNewswire/ --  DaVita Kidney Care  today announced the expansion of its home kidney care program to include the HomeChoice Claria Automated Peritoneal Dialysis (APD) system enable...

1 week ago - PRNewsWire

Herbalife (HLF), DaVita (DVA), Apple (AAPL), Century Communities (CCS) & Repligen (RGEN) are the top stocks that flaunt attractive earnings growth at present.

Other stocks mentioned: AAPL, CCS, HLF, RGEN
1 week ago - Zacks Investment Research

DaVita's (DVA) net dialysis and related lab-patient service revenues rise in Q1.

2 weeks ago - Zacks Investment Research

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 16.11% and -0.22%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

Shares of DaVita (NYSE:DVA) moved lower in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 14.21% year over year to $2.09, which beat the estimat...

2 weeks ago - Benzinga

DENVER, April 29, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2021. For the quarter, diluted earnings per share from continuing...

2 weeks ago - PRNewsWire

DENVER, April 27, 2021 /PRNewswire/ -- DaVita Inc. today announced its 2025 Environmental, Social and Governance (ESG) goals and released its new ESG reports, bolstering its commitment to corporate citi...

3 weeks ago - PRNewsWire

Solid performance by net dialysis and the related lab patient service segment are likely to have aided DaVita's (DVA) top line in the first quarter.

3 weeks ago - Zacks Investment Research

DENVER, April 22, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, April 29, 2021, at 5:00 p.m....

3 weeks ago - PRNewsWire

EAGAN, Minn., April 12, 2021 /PRNewswire/ -- Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced the launch of an innovative new program with VillageHealth − a DaVita integrated kidney ...

1 month ago - PRNewsWire

The following health care companies have grown their earnings per share over a five-year period. According to the GuruFocus discounted cash flow calculator as of March 31, all of them also trade with a ...

Other stocks mentioned: CHE, EBS, ICLR, SEM
1 month ago - GuruFocus

DaVita's (DVA) recent collaboration will help patients benefit from the portability, dependability and flexibility of NxStage home machines, designed to be easy to use.

1 month ago - Zacks Investment Research

DENVER, March 29, 2021 /PRNewswire/ -- DaVita today published its inaugural Diversity & Belonging (D&B) report, which discloses its diversity metrics and roadmap for delivering its vision of cultivating...

1 month ago - PRNewsWire

Since dialysis is a stable business, Davita Inc (NYSE: DVA) remained resilient during the pandemic. However, now with acceleration in volumes is poised to begin, the company “is not as levered to the ex...

1 month ago - Benzinga

With the trading day about halfway over, the broad markets were cautiously positive.

Other stocks mentioned: CSX, SNOW, ZM, GES, KNX, RH
1 month ago - 24/7 Wall Street

DENVER, March 25, 2021 /PRNewswire/ -- Today, the Biden administration announced a new partnership with dialysis providers to provide COVID-19 vaccinations to people receiving dialysis and health care p...

1 month ago - PRNewsWire

WALTHAM, Mass. and DENVER, March 23, 2021 /PRNewswire/ --  Fresenius Medical Care North America (FMCNA) and DaVita Kidney Care today announced an expanded agreement to provide home dialysis technology—i...

1 month ago - PRNewsWire

These stocks have not yet finished moving higher.

Other stocks mentioned: STNE, TMUS
2 months ago - The Motley Fool

SAN FRANCISCO, CA / ACCESSWIRE / March 16, 2021 / NephroSant, a kidney health spin out of UC San Francisco, today announced it has closed its oversubscribed Series A funding round of $16 million. DaVita...

2 months ago - Accesswire

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

DENVER, March 9, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced today that the company will participate in the 2021 Barclays Global Healthcare Conference. Joel Ackerman, DaVita's Chief Financial...

2 months ago - PRNewsWire

What are some examples of "cheap stocks" in today's still-strong stock market? These 9 may be great value plays to consider.

Other stocks mentioned: BBY, DXC, FOX, LUMN, MO, PFE, SFM ...
2 months ago - InvestorPlace

DENVER, Feb. 24, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private add-on offering of $750 million aggregate principal am...

2 months ago - PRNewsWire

Warren Buffett stocks may have more competition. But analysts agree a few big winners are good bets for the future — including some in the S&P 500.

Other stocks mentioned: AAPL, AMZN, LBTYA, RH, TMUS
2 months ago - Investors Business Daily

DENVER, Feb. 24, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private add-on offering of $750 million aggregate principal amount of its 4.625% senior n...

2 months ago - PRNewsWire

Francis Chou (Trades, Portfolio), manager of Chou Associates Management, disclosed last week that his firm's top four sells during the fourth quarter of 2020 included the closure of its position in Spir...

Other stocks mentioned: ALGT, GS, SAVE
2 months ago - GuruFocus

Investors' confidence is high on the DaVita (DVA) stock, thanks to solid prospects.

2 months ago - Zacks Investment Research

DaVita's (DVA) bottomline in Q4 declines year over year.

3 months ago - Zacks Investment Research

DaVita HealthCare (DVA) delivered earnings and revenue surprises of -9.73% and -1.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of DaVita (NYSE:DVA) decreased after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 10.22% year over year to $1.67, which missed the estimate of $...

3 months ago - Benzinga

BOSTON, Feb. 6, 2021 /PRNewswire/ -- Kyros Law Offices is alerting investors of Davita Inc (NYSE:DVA) that the deadline in filing claims from the investor lawsuit settlement against the company is fast ...

3 months ago - PRNewsWire

Solid performance by net dialysis and the related lab patient service segment is likely to have contributed to DaVita's (DVA) top line in the fourth quarter.

3 months ago - Zacks Investment Research

DENVER, Jan. 29, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 11, 2021, at 5:00 p...

3 months ago - PRNewsWire

3 Outpatient Home Health Stocks Set to Ride the Industry's Upturn

Other stocks mentioned: CHE, USPH
3 months ago - Zacks Investment Research

DaVita Inc. (NYSE: DVA) is focused on dialysis, which means that it is unlikely to get much of a boost from a reacceleration in volumes within health care, of which Tenet Healthcare Corp (NYSE: THC) is ...

4 months ago - Benzinga

Investor confidence is high on DaVita (DVA) stock, driven by its solid prospects.

4 months ago - Zacks Investment Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

4 months ago - Zacks Investment Research

DVA vs. CHE: Which Stock Is the Better Value Option?

Other stocks mentioned: CHE
4 months ago - Zacks Investment Research

DENVER, Dec. 22, 2020 /PRNewswire/ -- Today, DaVita Kidney Care announced that more than 100,000 DaVita patients have received a kidney transplant since 2000. This milestone represents the culmination o...

4 months ago - PRNewsWire

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

5 months ago - Zacks Investment Research

Some reasonably cheap stocks are growth stocks in disguise. If you're looking for undervalued stocks, these 10 are about to take off.

Other stocks mentioned: CWH, DG, GM, GOLD, HMC, INTC, NOAH ...
5 months ago - InvestorPlace

As uncertainty continues and growth stocks remain richly priced, these 10 value stocks could be your ticket to gains in 2021. The post The 10 Most Reliable Value Stocks to Buy for 2021 appeared first on...

Other stocks mentioned: CAH, GHC, HPQ, KR, MMM, MO, PPL ...
5 months ago - InvestorPlace

DVA vs. CHE: Which Stock Is the Better Value Option?

Other stocks mentioned: CHE
5 months ago - Zacks Investment Research

Markets rose on Thursday after jobless claims from last week came in at much better than expected figures. For investors looking to make the most of this market, our deep learning algorithms have crunch...

Other stocks mentioned: KW, MO, PRI, TGNA
5 months ago - Forbes

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

5 months ago - Zacks Investment Research

Is DaVita (DVA) a great pick from the value investor's perspective right now? Read on to know more.

5 months ago - Zacks Investment Research

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider DaVita (DVA).

5 months ago - Zacks Investment Research

As of late, it has definitely been a great time to be an investor in DaVita (DVA).

5 months ago - Zacks Investment Research

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. ... [Read more...]

Industry
Medical Care Facilities
IPO Date
Oct 31, 1995
CEO
Javier Rodriguez
Employees
67,000
Stock Exchange
NYSE
Ticker Symbol
DVA
Full Company Profile

Financial Performance

In 2020, DaVita's revenue was $11.55 billion, an increase of 1.42% compared to the previous year's $11.39 billion. Earnings were $773.64 million, a decrease of -4.60%.

Financial Statements

Analyst Forecasts

According to 12 analysts, the average rating for DaVita stock is "Hold." The 12-month stock price forecast is 123.71, which is an increase of 0.96% from the latest price.

Price Target
$123.71
(0.96% upside)
Analyst Consensus: Hold